Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
Thu, 08.05.2025
DocMorris AG
Frauenfeld, 8 May 2025
Press release
Ad hoc announcement pursuant to Art. 53 LR
DocMorris AG shareholders approve capital increase and all proposals put forward by the Board of Directors
At today's Annual General Meeting of DocMorris AG, shareholders approved all proposals put forward by the Board of Directors. They approved the ordinary capit [ … ]
Thu, 08.05.2025
OTRS AG
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN ANY JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.OTRS AG: Squeeze-out request submitted
Oberursel (Taunus), 8 May 2025:
OTRS AG (“Company”) (ISIN DE00A0S9R37, WKN A0S9R3) announces that Optimus BidCo AG, an acquisition c [ … ]
Thu, 08.05.2025
Cherry SE
Munich, 8 May 2025 – Cherry SE today entered into an agreement for the sale of the hygienic input devices business (formerly Active Key GmbH), part of the Cherry SE group, to the Danish peripherals manufacturer Contour Design Nordic A/S.
The agreed purchase price comprises a fixed component of EUR 12.5 million, payable upon closing and subject to [ … ]
Thu, 08.05.2025
Leonteq AG
PRESS RELEASE | LEONTEQ ANNOUNCES CHANGES TO ITS ORGANISATION
Zurich, 8 May 2025 | Ad hoc announcement pursuant to Art. 53 LR
Leonteq AG (SIX: LEON) today announced that it will resize its Executive Committee to enable faster decision-making and streamline internal processes. At the same time, the company will establish an extended senior mana [ … ]
Thu, 08.05.2025
DocMorris AG
Frauenfeld, 8 May 2025
Press release
Ad hoc announcement pursuant to Art. 53 LR
DocMorris announces final details on the agenda of today's Annual General Meeting and the planned capital increase
Final agenda items for today's Annual General Meeting
Details and conditions of the fully underwritten capital increase with subscription rights
Cont [ … ]
Wed, 07.05.2025
Holcim Group Services Ltd
Amrize completed another step toward the planned spin-off from Holcim with the update of its Form 10 Registration Statement, which includes Amrize’s first quarter 2025 financial statements prepared under U.S. GAAP. Holcim previously reported first quarter 2025 financials, including the Amrize business, in accordance with IFRS in its April 25 tradin [ … ]
Wed, 07.05.2025
Deutsche Konsum REIT-AG
Publication of inside information in accordance with Art. 17 para. 1 of Regulation (EU) 596/2014 on market abuse (market abuse regulation)
Deutsche Konsum REIT informs about the current status of the reorganisation planning
Potsdam, Germany, 7 May 2024 – Deutsche Konsum REIT-AG (the "Company") (ISIN: DE000A14KRD3 | WKN: A14KRD | ticker symbol: DK [ … ]
Wed, 07.05.2025
Brockhaus Technologies AG
Brockhaus Technologies AG: Preliminary revenue for Q1 2025 at €42.4 million and adjusted EBITDA at €2.4 million
Frankfurt am Main, May 7, 2025
Brockhaus Technologies AG (BKHT, ISIN: DE000A2GSU42, "Brockhaus Technologies") achieved revenue of €42.4 million in the first quarter of the financial year 2025 according to preliminary figures, representi [ … ]
Wed, 07.05.2025
INDUS Holding AG
Publication of inside information pursuant to Article 17 of Regulation (EU) No 596/2014
Keywords: Change in forecastINDUS reduces forecast for sales, adjusted EBITA and adjusted EBITA margin for the 2025 financial year
Bergisch Gladbach, May 07, 2025 - INDUS Holding AG (ISIN: DE0006200108) is adjusting its forecast for sales, adjusted EBITA and adj [ … ]
Wed, 07.05.2025
Carl Zeiss Meditec AG
Change of President and CEO at Carl Zeiss Meditec AG
Jena, May 7, 2025
The supervisory board of Carl Zeiss Meditec AG (ISIN: DE0005313704) in today’s meeting has agreed on a change in the Management Board of the company. Dr. Markus Weber, President and CEO of Carl Zeiss Meditec AG since January 1, 2022, will turn over his position to Maxi [ … ]